| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Advancing precision medicine with personalized drug screening
|
Gorshkov, Kirill
|
|
|
24 |
1 |
p. 272-278
|
artikel
|
| 2 |
Antithrombotic P2Y12 receptor antagonists: recent developments in drug discovery
|
Baqi, Younis
|
|
|
24 |
1 |
p. 325-333
|
artikel
|
| 3 |
Artificial intelligence and its potential in oncology
|
Londhe, Vaishali Y.
|
|
|
24 |
1 |
p. 228-232
|
artikel
|
| 4 |
A well-tolerated and rapidly acting thiopurine for IBD?
|
Florin, Timothy H.J.
|
|
|
24 |
1 |
p. 37-41
|
artikel
|
| 5 |
Basic and practical concepts of radiopharmaceutical purification methods
|
Molavipordanjani, Sajjad
|
|
|
24 |
1 |
p. 315-324
|
artikel
|
| 6 |
Bile acid homeostasis paradigm and its connotation with cholestatic liver diseases
|
Yang, Tingting
|
|
|
24 |
1 |
p. 112-128
|
artikel
|
| 7 |
Biosimilar medicines used for cancer therapy in Europe: a review
|
Santos, Sofia B.
|
|
|
24 |
1 |
p. 293-299
|
artikel
|
| 8 |
Cnidarian peptide neurotoxins: a new source of various ion channel modulators or blockers against central nervous systems disease
|
Liao, Qiwen
|
|
|
24 |
1 |
p. 189-197
|
artikel
|
| 9 |
Considerations for implementing an informatics system to support biologics drug discovery
|
LeBeau, Andrew P.
|
|
|
24 |
1 |
p. 42-45
|
artikel
|
| 10 |
Contents page 2
|
|
|
|
24 |
1 |
p. ii
|
artikel
|
| 11 |
Contents page 1
|
|
|
|
24 |
1 |
p. i
|
artikel
|
| 12 |
Copies of nonbiological complex drugs: generic, hybrid or biosimilar?
|
Rocco, Paolo
|
|
|
24 |
1 |
p. 250-255
|
artikel
|
| 13 |
Design strategies for chemical-stimuli-responsive programmable nanotherapeutics
|
Gulfam, Muhammad
|
|
|
24 |
1 |
p. 129-147
|
artikel
|
| 14 |
3D in vitro models of tumors expressing EGFR family receptors: a potent tool for studying receptor biology and targeted drug development
|
Sokolova, Evgeniya A.
|
|
|
24 |
1 |
p. 99-111
|
artikel
|
| 15 |
Do urocortins have a role in treating cardiovascular disease?
|
Chatzaki, Ekaterini
|
|
|
24 |
1 |
p. 279-284
|
artikel
|
| 16 |
Drug-Induced Rhabdomyolysis Atlas (DIRA) for idiosyncratic adverse drug reaction management
|
Wen, Zhining
|
|
|
24 |
1 |
p. 9-15
|
artikel
|
| 17 |
Effects of antidiabetic drugs on NLRP3 inflammasome activity, with a focus on diabetic kidneys
|
Yaribeygi, Habib
|
|
|
24 |
1 |
p. 256-262
|
artikel
|
| 18 |
Factors and situations influencing the value of patient preference studies along the medical product lifecycle: a literature review
|
van Overbeeke, Eline
|
|
|
24 |
1 |
p. 57-68
|
artikel
|
| 19 |
FoxO1–miRNA interacting networks as potential targets for mitochondrial diseases
|
Puthanveetil, Prasanth
|
|
|
24 |
1 |
p. 342-349
|
artikel
|
| 20 |
Functionalizing bioinks for 3D bioprinting applications
|
Parak, Azraa
|
|
|
24 |
1 |
p. 198-205
|
artikel
|
| 21 |
Fungal immunomodulatory proteins: characteristic, potential antitumor activities and their molecular mechanisms
|
Li, Qi-Zhang
|
|
|
24 |
1 |
p. 307-314
|
artikel
|
| 22 |
How soon will digital endpoints become a cornerstone for future drug development?
|
Boehme, Philip
|
|
|
24 |
1 |
p. 16-19
|
artikel
|
| 23 |
Implications of human induced pluripotent stem cells in metabolic disorders: from drug discovery toward precision medicine
|
Cota-Coronado, Agustin
|
|
|
24 |
1 |
p. 334-341
|
artikel
|
| 24 |
MCR-1: a promising target for structure-based design of inhibitors to tackle polymyxin resistance
|
Son, Soo Jung
|
|
|
24 |
1 |
p. 206-216
|
artikel
|
| 25 |
Micro- and nano-formulations for bioprinting and additive manufacturing
|
Bouguéon, Guillaume
|
|
|
24 |
1 |
p. 163-178
|
artikel
|
| 26 |
microRNAs and cardiac stem cells in heart development and disease
|
Li, Bo
|
|
|
24 |
1 |
p. 233-240
|
artikel
|
| 27 |
New leads for drug repurposing against malaria
|
Pazhayam, Nila Madassary
|
|
|
24 |
1 |
p. 263-271
|
artikel
|
| 28 |
Patent term restoration for top-selling drugs in the United States
|
Beall, Reed F.
|
|
|
24 |
1 |
p. 20-25
|
artikel
|
| 29 |
Peptide-based therapeutics: quality specifications, regulatory considerations, and prospects
|
Rastogi, Shruti
|
|
|
24 |
1 |
p. 148-162
|
artikel
|
| 30 |
Polycomb repressive complex 2 inhibitors: emerging epigenetic modulators
|
Danishuddin,
|
|
|
24 |
1 |
p. 179-188
|
artikel
|
| 31 |
Renovation as innovation: is repurposing the future of drug discovery research?
|
Neuberger, Arthur
|
|
|
24 |
1 |
p. 1-3
|
artikel
|
| 32 |
Safety differentiation: emerging competitive edge in drug development
|
Uteng, Marianne
|
|
|
24 |
1 |
p. 285-292
|
artikel
|
| 33 |
Small molecules for fat combustion: targeting thermosensory and satiety signals in the central nervous system
|
Liu, Jingxin
|
|
|
24 |
1 |
p. 300-306
|
artikel
|
| 34 |
Src and podoplanin forge a path to destruction
|
Krishnan, Harini
|
|
|
24 |
1 |
p. 241-249
|
artikel
|
| 35 |
Streamlining nonclinical drug development using the FDA 505(b)(2) new drug application regulatory pathway
|
Salminen, William F.
|
|
|
24 |
1 |
p. 46-56
|
artikel
|
| 36 |
Targeting intrinsically disordered proteins at the edge of chaos
|
Ruan, Hao
|
|
|
24 |
1 |
p. 217-227
|
artikel
|
| 37 |
The Clinical Innovation Network: a policy for promoting development of drugs and medical devices in Japan
|
Matsushita, Shunsuke
|
|
|
24 |
1 |
p. 4-8
|
artikel
|
| 38 |
Therapeutic potential of endogenous stem cells and cellular factors for scar-free skin regeneration
|
Giri, Shibashish
|
|
|
24 |
1 |
p. 69-84
|
artikel
|
| 39 |
The use of nanoparticles as biomaterials in dentistry
|
Bapat, Ranjeet A.
|
|
|
24 |
1 |
p. 85-98
|
artikel
|
| 40 |
Translational in vitro research: integrating 3D drug discovery and development processes into the drug development pipeline
|
Kelm, Jens M.
|
|
|
24 |
1 |
p. 26-30
|
artikel
|
| 41 |
Turning straw into gold: building robustness into gene signature inference
|
Goh, Wilson Wen Bin
|
|
|
24 |
1 |
p. 31-36
|
artikel
|
| 42 |
Updates on the pathogenicity status of Pseudomonas aeruginosa
|
Azam, Mohd W.
|
|
|
24 |
1 |
p. 350-359
|
artikel
|
Tijdschrift beschrijving